Alevin Therapeutics

Description: Alevin Therapeutics develops breakthrough integrin inhibitors to treat life-threatening fibrotic diseases with safe, effective medicines.

Country: UK

Based in: Cambridge

Founded: 2022

Funding Stage: Pre-Seed

Tags: ['Biotechnology company', 'Integrin inhibitors', 'Fibrotic diseases']

Categories

Add insights to your inbox

We’ll send you content you’ll want to read- and put to use.

Details about how we process your information are available in our Privacy Policy.